Ribosomal DNA Abundance in the Patient's Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia.
Ershova ES, Veiko NN, Nikitina SG, Balakireva EE, Martynov AV, Chudakova JM, Shmarina GV, Kostyuk SE, Salimova NA, Veiko RV, Porokhovnik LN, Asanov AY, Izhevskaia VL, Kutsev SI, Simashkova NV, Kostyuk SV.
Ershova ES, et al. Among authors: veiko nn.
J Pers Med. 2022 Oct 31;12(11):1796. doi: 10.3390/jpm12111796.
J Pers Med. 2022.
PMID: 36579513
Free PMC article.